Home

Market Capitalization of Transgene Biotek Ltd

Image

Transgene Biotek Ltd

NSE: TRANSGENEBIOTEK

Market Cap

₹ 32.05 crore

Last updated on: Feb 21, 2025

Key Highlights

  • The Market Cap of Transgene Biotek Ltd is ₹ 32.05 crore as of 21 Feb 25 .
  • The Latest Trading Price of Transgene Biotek Ltd is ₹ 4.23 as of 21 Feb 15:30 .
Image

Transgene Biotek Ltd

NSE: TRANSGENEBIOTEK

Share Price

₹ 4.23

-0.02 (-0.47%)

stock direction

Last updated on: Feb 21, 2025

Market Price of Transgene Biotek Ltd

1M

1Y

3Y

5Y

Monitoring Transgene Biotek Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Feb 20254.23
20 Feb 20254.25
19 Feb 20254.25
18 Feb 20254.06
17 Feb 20254.2
14 Feb 20254.4
13 Feb 20254.31
12 Feb 20254.43
11 Feb 20254.34
10 Feb 20254.47

SWOT Analysis Of Transgene Biotek Ltd

Strength

1

che

Weakness

2

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Transgene Biotek Ltd

Asset Value vs Market Value of Transgene Biotek Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of Market Cap

Key Valuation Metric of Transgene Biotek Ltd

No data available

No data available

Historical P/E Ratio of Transgene Biotek Ltd

No data available

* All values are in %

Historical Revenue of Transgene Biotek Ltd

No data available

* All values are in crore

Historical EBITDA of Transgene Biotek Ltd

No data available

* All values are in crore

Historical Net Profit of Transgene Biotek Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

About Transgene Biotek Ltd

  • Founded in March, 1990 by Dr. Koteswara Rao, Transgene Biotek Ltd was one of the first Biotechnology companies in India.
  • Although Transgene began life manufacturing and selling diagnostic kits, it soon moved on to true biotech research, including the research and development of vaccines, oncology , New drug delivery technologies etc.
  • The first major success came when it sold genetically engineered recombinant Hepatitis B vaccine technology along with novel and patented process in 1999 to the Serum Institute, Pune. Presently, the Company is engaged in the business of research and development and manufacture of various medical reagents, both chemical and immuno-diagnostic reagents for qualitative and quantitative estimation of bio-chemical parameters and diagnosis of diseases respectively.

Transgene Biotek Ltd News Hub

Transgene Biotek reports consolidated net profit of Rs 0.20 crore in the June 2024 quarter

Net profit of Transgene Biotek reported to Rs 0.20 crore in the quarter ended June 2024 as against n

Read more

12 Aug 24

Transgene Biotek to announce Quarterly Result

Transgene Biotek will hold a meeting of the Board of Directors of the Company on 12 November 2024 Po

Read more

05 Nov 24

Transgene Biotek reports consolidated net loss of Rs 0.07 crore in the September 2024 quarter

Net Loss of Transgene Biotek reported to Rs 0.07 crore in the quarter ended September 2024 as agains

Read more

12 Nov 24

Transgene Biotek declare Quarterly Result

Transgene Biotek will hold a meeting of the Board of Directors of the Company on 24 January 2025. Po

Read more

17 Jan 25

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Transgene Biotek Ltd Market Cap

What is the market cap of Transgene Biotek Ltd?

As of February 22, 2025, Transgene Biotek Ltd has a market capitalization of ₹32.05, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Transgene Biotek Ltd's market capitalization?

Transgene Biotek Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Transgene Biotek Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Transgene Biotek Ltd's market capitalization change?

Transgene Biotek Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions